{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:45:30Z","timestamp":1785843930663,"version":"3.56.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12534-y","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:08:08Z","timestamp":1785841688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recent trends in modified mesenchymal stromal cells: engineering approaches and international regulatory landscape"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9905-1726","authenticated-orcid":false,"given":"S. Gokul","family":"Krishna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9797-8027","authenticated-orcid":false,"given":"Smitha","family":"Panigrahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5235-0828","authenticated-orcid":false,"given":"Uday Kumar","family":"Kolkundkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9027-2234","authenticated-orcid":false,"given":"Suresh","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"12534_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.omtn.2021.08.013","volume":"26","author":"S Wang","year":"2021","unstructured":"Wang S, Wang Z, Su H et al (2021) Effects of long-term culture on the biological characteristics and RNA profiles of human bone-marrow-derived mesenchymal stem cells. Mol Ther - Nucleic Acids 26:557\u2013574. https:\/\/doi.org\/10.1016\/j.omtn.2021.08.013","journal-title":"Mol Ther - Nucleic Acids"},{"key":"12534_CR2","doi-asserted-by":"publisher","first-page":"151634","DOI":"10.1016\/j.acthis.2020.151634","volume":"122","author":"B Ugurlu","year":"2020","unstructured":"Ugurlu B, Karaoz E (2020) Comparison of similar cells: Mesenchymal stromal cells and fibroblasts. Acta Histochem 122:151634. https:\/\/doi.org\/10.1016\/j.acthis.2020.151634","journal-title":"Acta Histochem"},{"key":"12534_CR3","doi-asserted-by":"publisher","first-page":"11592","DOI":"10.3390\/ijms222111592","volume":"22","author":"M Sarsenova","year":"2021","unstructured":"Sarsenova M, Issabekova A, Abisheva S et al (2021) Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis. Int J Mol Sci 22:11592. https:\/\/doi.org\/10.3390\/ijms222111592","journal-title":"Int J Mol Sci"},{"key":"12534_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.omtm.2021.05.018","volume":"23","author":"AI Nyk\u00e4nen","year":"2021","unstructured":"Nyk\u00e4nen AI, Mariscal A, Duong A et al (2021) Engineered mesenchymal stromal cell therapy during human lung ex vivo lung perfusion is compromised by acidic lung microenvironment. Mol Ther - Methods Clin Dev 23:184\u2013197. https:\/\/doi.org\/10.1016\/j.omtm.2021.05.018","journal-title":"Mol Ther - Methods Clin Dev"},{"key":"12534_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s13287-020-01920-3","volume":"11","author":"B-C Lee","year":"2020","unstructured":"Lee B-C, Kang K-S (2020) Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application. Stem Cell Res Ther 11:397. https:\/\/doi.org\/10.1186\/s13287-020-01920-3","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR6","doi-asserted-by":"publisher","first-page":"16946","DOI":"10.1038\/s41598-020-74066-0","volume":"10","author":"W Lech","year":"2020","unstructured":"Lech W, Sarnowska A, Kuczynska Z et al (2020) Biomimetic microenvironmental preconditioning enhance neuroprotective properties of human mesenchymal stem cells derived from Wharton\u2019s Jelly (WJ-MSCs). Sci Rep 10:16946. https:\/\/doi.org\/10.1038\/s41598-020-74066-0","journal-title":"Sci Rep"},{"key":"12534_CR7","unstructured":"The PRISMA (2020) statement : an updated guideline for reporting systematic reviews | The BMJ. https:\/\/www.bmj.com\/content\/372\/bmj.n71. Accessed 17 May 2026"},{"key":"12534_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/cei\/uxac016","volume":"208","author":"S Keshavarz Shahbaz","year":"2022","unstructured":"Keshavarz Shahbaz S, Mansourabadi AH, Jafari D (2022) Genetically engineered mesenchymal stromal cells as a new trend for treatment of severe acute graft-versus-host disease. Clin Exp Immunol 208:12\u201324. https:\/\/doi.org\/10.1093\/cei\/uxac016","journal-title":"Clin Exp Immunol"},{"key":"12534_CR9","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3390\/ijms20051195","volume":"20","author":"C Mas-Bargues","year":"2019","unstructured":"Mas-Bargues C, Sanz-Ros J, Rom\u00e1n-Dom\u00ednguez A et al (2019) Relevance of Oxygen Concentration in Stem Cell Culture for Regenerative Medicine. Int J Mol Sci 20:1195. https:\/\/doi.org\/10.3390\/ijms20051195","journal-title":"Int J Mol Sci"},{"key":"12534_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s12964-025-02497-1","volume":"23","author":"X Luo","year":"2025","unstructured":"Luo X, Zeng W, Xiong E et al (2025) Hypoxia-preconditioning human bone marrow-derived mesenchymal stem cells induce high-quality mitochondrial transfer through gap junctions to alleviate ischemia-reperfusion injury in liver graft. Cell Commun Signal 23:495. https:\/\/doi.org\/10.1186\/s12964-025-02497-1","journal-title":"Cell Commun Signal"},{"key":"12534_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.reth.2025.06.005","volume":"30","author":"T Takehara","year":"2025","unstructured":"Takehara T, Tsujimoto T, Ikebuchi F et al (2025) BNIP3 induced by hypoxia supports the survival of mesenchymal stromal cells (MSCs) after intravenous cell transplantation. Regen Ther 30:224\u2013233. https:\/\/doi.org\/10.1016\/j.reth.2025.06.005","journal-title":"Regen Ther"},{"key":"12534_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40779-024-00550-7","volume":"11","author":"Y Zhuo","year":"2024","unstructured":"Zhuo Y, Li W-S, Lu W et al (2024) TGF-\u03b21 mediates hypoxia-preconditioned olfactory mucosa mesenchymal stem cells improved neural functional recovery in Parkinson\u2019s disease models and patients. Mil Med Res 11:48. https:\/\/doi.org\/10.1186\/s40779-024-00550-7","journal-title":"Mil Med Res"},{"key":"12534_CR13","doi-asserted-by":"publisher","first-page":"2597612","DOI":"10.1080\/09513590.2025.2597612","volume":"41","author":"M Gu","year":"2025","unstructured":"Gu M, Ruan X, Cheng J et al (2025) Hypoxia-preconditioned hUCMSCs protect frozen-thawed human ovarian tissue by modulating the HIF-1\u03b1\/VEGF pathway. Gynecol Endocrinol 41:2597612. https:\/\/doi.org\/10.1080\/09513590.2025.2597612","journal-title":"Gynecol Endocrinol"},{"key":"12534_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13018-021-02908-2","volume":"17","author":"X Guo","year":"2022","unstructured":"Guo X, Huang D, Li D et al (2022) Adipose-derived mesenchymal stem cells with hypoxic preconditioning improve tenogenic differentiation. J Orthop Surg 17:49. https:\/\/doi.org\/10.1186\/s13018-021-02908-2","journal-title":"J Orthop Surg"},{"key":"12534_CR15","doi-asserted-by":"publisher","unstructured":"Huang Y, Tan F, Zhuo Y et al (2020) Hypoxia-preconditioned olfactory mucosa mesenchymal stem cells abolish cerebral ischemia\/reperfusion-induced pyroptosis and apoptotic death of microglial cells by activating HIF-1\u03b1. Aging 10931\u201310950. https:\/\/doi.org\/10.18632\/aging.103307","DOI":"10.18632\/aging.103307"},{"key":"12534_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13287-020-01642-6","volume":"11","author":"N Ishiuchi","year":"2020","unstructured":"Ishiuchi N, Nakashima A, Doi S et al (2020) Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats. Stem Cell Res Ther 11:130. https:\/\/doi.org\/10.1186\/s13287-020-01642-6","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13287-024-03778-1","volume":"15","author":"GK Sohi","year":"2024","unstructured":"Sohi GK, Farooqui N, Mohan A et al (2024) The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease. Stem Cell Res Ther 15:162. https:\/\/doi.org\/10.1186\/s13287-024-03778-1","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR18","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s13287-022-03167-6","volume":"13","author":"J Cheng","year":"2022","unstructured":"Cheng J, Ruan X, Li Y et al (2022) Effects of hypoxia-preconditioned HucMSCs on neovascularization and follicle survival in frozen\/thawed human ovarian cortex transplanted to immunodeficient mice. Stem Cell Res Ther 13:474. https:\/\/doi.org\/10.1186\/s13287-022-03167-6","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR19","doi-asserted-by":"publisher","first-page":"36055","DOI":"10.1038\/s41598-025-20018-5","volume":"15","author":"NT-H Dinh","year":"2025","unstructured":"Dinh NT-H, Nguyen QT, Hang NT et al (2025) Assessment of the safety of hypoxia-primed mesenchymal stem cells derived from umbilical cord and adipose tissues in animals. Sci Rep 15:36055. https:\/\/doi.org\/10.1038\/s41598-025-20018-5","journal-title":"Sci Rep"},{"key":"12534_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12896-025-00993-3","volume":"25","author":"S Yang","year":"2025","unstructured":"Yang S, Zhuang W, Zhou L et al (2025) An engineered hypoxia-response promoter for human umbilical cord-derived mesenchymal stem cell-based therapeutics. BMC Biotechnol 25:59. https:\/\/doi.org\/10.1186\/s12896-025-00993-3","journal-title":"BMC Biotechnol"},{"key":"12534_CR21","doi-asserted-by":"publisher","first-page":"8160","DOI":"10.3390\/ijms22158160","volume":"22","author":"K Zielniok","year":"2021","unstructured":"Zielniok K, Burdzinska A, Murcia Pienkowski V et al (2021) Gene Expression Profile of Human Mesenchymal Stromal Cells Exposed to Hypoxic and Pseudohypoxic Preconditioning\u2014An Analysis by RNA Sequencing. Int J Mol Sci 22:8160. https:\/\/doi.org\/10.3390\/ijms22158160","journal-title":"Int J Mol Sci"},{"key":"12534_CR22","doi-asserted-by":"publisher","first-page":"2500663","DOI":"10.1002\/adhm.202500663","volume":"14","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Qian M, Shi Y et al (2025) Engineered MSC Aggregates with E\/N-Cadherin and IL\u20106 Preconditioning for the Treatment of Systemic Sclerosis. Adv Healthc Mater 14:2500663. https:\/\/doi.org\/10.1002\/adhm.202500663","journal-title":"Adv Healthc Mater"},{"key":"12534_CR23","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1177\/0271678X231197109","volume":"43","author":"R Wong","year":"2023","unstructured":"Wong R, Smith CJ, Allan SM, Pinteaux E (2023) Preconditioning with interleukin-1 alpha is required for the neuroprotective properties of mesenchymal stem cells after ischemic stroke in mice. J Cereb Blood Flow Metab 43:2040\u20132048. https:\/\/doi.org\/10.1177\/0271678X231197109","journal-title":"J Cereb Blood Flow Metab"},{"key":"12534_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13287-020-1560-y","volume":"11","author":"CJ Cunningham","year":"2020","unstructured":"Cunningham CJ, Wong R, Barrington J et al (2020) Systemic conditioned medium treatment from interleukin-1 primed mesenchymal stem cells promotes recovery after stroke. Stem Cell Res Ther 11:32. https:\/\/doi.org\/10.1186\/s13287-020-1560-y","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR25","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s13770-021-00350-3","volume":"18","author":"M Yoo","year":"2021","unstructured":"Yoo M, Cho S, Shin S et al (2021) Therapeutic Effect of IL1\u03b2 Priming Tonsil Derived-Mesenchymal Stem Cells in Osteoporosis. Tissue Eng Regen Med 18:851\u2013862. https:\/\/doi.org\/10.1007\/s13770-021-00350-3","journal-title":"Tissue Eng Regen Med"},{"key":"12534_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41419-023-05597-3","volume":"14","author":"Y Liao","year":"2023","unstructured":"Liao Y, Fu Z, Huang Y et al (2023) Interleukin-18-primed human umbilical cord-mesenchymal stem cells achieve superior therapeutic efficacy for severe viral pneumonia via enhancing T-cell immunosuppression. Cell Death Dis 14:66. https:\/\/doi.org\/10.1038\/s41419-023-05597-3","journal-title":"Cell Death Dis"},{"key":"12534_CR27","doi-asserted-by":"publisher","first-page":"9436","DOI":"10.3390\/ijms26199436","volume":"26","author":"P Mallis","year":"2025","unstructured":"Mallis P, Chatzistamatiou T, Gkatzoflia E et al (2025) The Impact of IFN-\u03b3 Licensing on Mesenchymal Stromal Cells\u2019 Mediated Immunoregulation and HLA Class II Expression: Emerging Evidence from In Vitro Results. Int J Mol Sci 26:9436. https:\/\/doi.org\/10.3390\/ijms26199436","journal-title":"Int J Mol Sci"},{"key":"12534_CR28","doi-asserted-by":"publisher","first-page":"1473788","DOI":"10.3389\/fimmu.2025.1473788","volume":"16","author":"J Valencia","year":"2025","unstructured":"Valencia J, Y\u00e1\u00f1ez RM, Munti\u00f3n S et al (2025) Improving the therapeutic profile of MSCs: Cytokine priming reduces donor-dependent heterogeneity and enhances their immunomodulatory capacity. Front Immunol 16:1473788. https:\/\/doi.org\/10.3389\/fimmu.2025.1473788","journal-title":"Front Immunol"},{"key":"12534_CR29","doi-asserted-by":"publisher","first-page":"e2281","DOI":"10.52225\/narra.v5i2.2281","volume":"5","author":"E Widaja","year":"2025","unstructured":"Widaja E, Pawitan JA, Ramli Y (2025) Therapeutic potential of hUC-MSC secretome preconditioned with IFN-\u03b3 and\/or TNF-\u03b1: An in vitro study on Alzheimer\u2019s neuronal cell models. Narra J 5:e2281. https:\/\/doi.org\/10.52225\/narra.v5i2.2281","journal-title":"Narra J"},{"key":"12534_CR30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13287-025-04394-3","volume":"16","author":"J-H Nam","year":"2025","unstructured":"Nam J-H, Moon JH, Choi B et al (2025) IFN-\u03b1 and vitamin B6-induced galectin-9 promotes the immunomodulatory function of human clonal mesenchymal stem cells. Stem Cell Res Ther 16:270. https:\/\/doi.org\/10.1186\/s13287-025-04394-3","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/ph16020149","volume":"16","author":"D Byrnes","year":"2023","unstructured":"Byrnes D, Masterson CH, Brady J et al (2023) Differential Effects of Cytokine Versus Hypoxic Preconditioning of Human Mesenchymal Stromal Cells in Pulmonary Sepsis Induced by Antimicrobial-Resistant Klebsiella pneumoniae. Pharmaceuticals 16:149. https:\/\/doi.org\/10.3390\/ph16020149","journal-title":"Pharmaceuticals"},{"key":"12534_CR32","doi-asserted-by":"publisher","first-page":"101616","DOI":"10.1016\/j.omtm.2025.101616","volume":"33","author":"J Zhao","year":"2025","unstructured":"Zhao J, Yu B, Fradette J et al (2025) Preconditioning with StemRegenin 1 enhances human adipose stromal\/stem cells proliferation, migration, and protection against antimycin A. Mol Ther Methods Clin Dev 33:101616. https:\/\/doi.org\/10.1016\/j.omtm.2025.101616","journal-title":"Mol Ther Methods Clin Dev"},{"key":"12534_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12964-021-00815-x","volume":"20","author":"CCH Mak","year":"2022","unstructured":"Mak CCH, To K, Fekir K et al (2022) Infrapatellar fat pad adipose-derived stem cells co-cultured with articular chondrocytes from osteoarthritis patients exhibit increased chondrogenic gene expression. Cell Commun Signal 20:17. https:\/\/doi.org\/10.1186\/s12964-021-00815-x","journal-title":"Cell Commun Signal"},{"key":"12534_CR34","doi-asserted-by":"publisher","first-page":"9569","DOI":"10.3390\/ijms24119569","volume":"24","author":"AA Subayyil","year":"2023","unstructured":"Subayyil AA, Basmaeil YS, Kulayb HB et al (2023) Preconditioned Chorionic Villus Mesenchymal Stem\/Stromal Cells (CVMSCs) Minimize the Invasive Phenotypes of Breast Cancer Cell Line MDA231 In Vitro. Int J Mol Sci 24:9569. https:\/\/doi.org\/10.3390\/ijms24119569","journal-title":"Int J Mol Sci"},{"key":"12534_CR35","doi-asserted-by":"publisher","first-page":"e6964","DOI":"10.1002\/cam4.6964","volume":"13","author":"D Ka\u00e7aro\u011flu","year":"2024","unstructured":"Ka\u00e7aro\u011flu D, Yaylac\u0131 S, Gurbuz N (2024) Anti-tumorigenic effects of naive and TLR4\u2010primed adipose\u2010derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells. Cancer Med 13:e6964. https:\/\/doi.org\/10.1002\/cam4.6964","journal-title":"Cancer Med"},{"key":"12534_CR36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/cells14030174","volume":"14","author":"RS Meenakshi Sundaram","year":"2025","unstructured":"Meenakshi Sundaram RS, Rupert S, Srinivasan P et al (2025) Decoding Cytokine Dynamics: Wharton\u2019s Jelly Stromal Cells and Chondro-Differentiates in PHA-Stimulated Co-Culture. Cells 14:174. https:\/\/doi.org\/10.3390\/cells14030174","journal-title":"Cells"},{"key":"12534_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6663467","volume":"2021","author":"FK Touani","year":"2021","unstructured":"Touani FK, Borie M, Azzi F et al (2021) Pharmacological Preconditioning Improves the Viability and Proangiogenic Paracrine Function of Hydrogel-Encapsulated Mesenchymal Stromal Cells. Stem Cells Int 2021:1\u201312. https:\/\/doi.org\/10.1155\/2021\/6663467","journal-title":"Stem Cells Int"},{"key":"12534_CR38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.7150\/ntno.81019","volume":"7","author":"GA-E Tawfeek","year":"2023","unstructured":"Tawfeek GA-E, Kasem HA, Elshoala SE (2023) Curcumin Nanofiber PCL\/PLGA\/Collagen Enhanced the Therapeutic Efficacy of Mesenchymal Stem Cells against Liver Fibrosis in Animal Model and Prevented its Recurrence. Nanotheranostics 7:299\u2013315. https:\/\/doi.org\/10.7150\/ntno.81019","journal-title":"Nanotheranostics"},{"key":"12534_CR39","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3390\/cells11040709","volume":"11","author":"G Zito","year":"2022","unstructured":"Zito G, Miceli V, Carcione C et al (2022) Human Amnion-Derived Mesenchymal Stromal\/Stem Cells Pre-Conditioning Inhibits Inflammation and Apoptosis of Immune and Parenchymal Cells in an In Vitro Model of Liver Ischemia\/Reperfusion. Cells 11:709. https:\/\/doi.org\/10.3390\/cells11040709","journal-title":"Cells"},{"key":"12534_CR40","doi-asserted-by":"publisher","first-page":"22625","DOI":"10.1038\/s41598-025-04269-w","volume":"15","author":"W Lech","year":"2025","unstructured":"Lech W, Kot M, Welniak-Kaminska M et al (2025) Dynamic changes in BDNF, VEGF, and GDNF after transplanting human protein-based scaffolds with Wharton\u2019s Jelly MSCs in a rat brain injury model. Sci Rep 15:22625. https:\/\/doi.org\/10.1038\/s41598-025-04269-w","journal-title":"Sci Rep"},{"key":"12534_CR41","doi-asserted-by":"publisher","first-page":"7013","DOI":"10.3390\/ijms21197013","volume":"21","author":"N-H Lee","year":"2020","unstructured":"Lee N-H, Myeong SH, Son HJ et al (2020) Ethionamide Preconditioning Enhances the Proliferation and Migration of Human Wharton\u2019s Jelly-Derived Mesenchymal Stem Cells. Int J Mol Sci 21:7013. https:\/\/doi.org\/10.3390\/ijms21197013","journal-title":"Int J Mol Sci"},{"key":"12534_CR42","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.7150\/thno.104143","volume":"15","author":"L Olmedo-Moreno","year":"2025","unstructured":"Olmedo-Moreno L, Panadero-Mor\u00f3n C, Sierra-P\u00e1rraga JM et al (2025) Glioblastoma progression is hindered by melatonin-primed mesenchymal stromal cells through dynamic intracellular and extracellular reorganizations. Theranostics 15:3076\u20133097. https:\/\/doi.org\/10.7150\/thno.104143","journal-title":"Theranostics"},{"key":"12534_CR43","doi-asserted-by":"publisher","unstructured":"I\u015f\u0131ldar B, \u00d6zkan S, Koyut\u00fcrk M (2024) Preconditioning of Human Umbilical Cord Mesenchymal Stem Cells with a Histone Deacetylase Inhibitor: Valproic Acid. Balk Med J 369\u2013376. https:\/\/doi.org\/10.4274\/balkanmedj.galenos.2024.2024-6-25","DOI":"10.4274\/balkanmedj.galenos.2024.2024-6-25"},{"key":"12534_CR44","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.tjog.2023.07.007","volume":"62","author":"L Jalali","year":"2023","unstructured":"Jalali L, Allahveisie A, Rezaei S et al (2023) Effect of preconditioning of human umbilical cord mesenchymal stem cells with hydrogen peroxide on the therapeutic potential of MSCs in the cyclophosphamide -induced premature ovarian failure mice model. Taiwan J Obstet Gynecol 62:667\u2013676. https:\/\/doi.org\/10.1016\/j.tjog.2023.07.007","journal-title":"Taiwan J Obstet Gynecol"},{"key":"12534_CR45","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1186\/s13287-025-04593-y","volume":"16","author":"MJ Lee","year":"2025","unstructured":"Lee MJ, Kim SH, Shin S et al (2025) Platelet-rich plasma enhances local homing of umbilical cord-derived mesenchymal stem cells to articular cartilage by increasing the quantity and activation of integrin \ua7b51. Stem Cell Res Ther 16:487. https:\/\/doi.org\/10.1186\/s13287-025-04593-y","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR46","doi-asserted-by":"publisher","first-page":"117745","DOI":"10.1016\/j.biopha.2024.117745","volume":"182","author":"PT Nguyen","year":"2025","unstructured":"Nguyen PT, Seo Y, Ahn J-S et al (2025) De novo interleukin-10 production primed by Lactobacillus sakei CVL-001 amplifies the immunomodulatory abilities of mesenchymal stem cells to alleviate colitis. Biomed Pharmacother 182:117745. https:\/\/doi.org\/10.1016\/j.biopha.2024.117745","journal-title":"Biomed Pharmacother"},{"key":"12534_CR47","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2020.11380","author":"R Li","year":"2020","unstructured":"Li R, Li Y, Dong X (2020) Preconditioning mesenchymal stromal cells with flagellin enhances the anti\u2013inflammatory ability of their secretome against lipopolysaccharide\u2013induced acute lung injury. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2020.11380","journal-title":"Mol Med Rep"},{"key":"12534_CR48","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/medicina59030587","volume":"59","author":"AJ Cumpata","year":"2023","unstructured":"Cumpata AJ, Peptanariu D, Lungoci A-L et al (2023) Towards Regenerative Audiology: Immune Modulation of Adipose-Derived Mesenchymal Cells Preconditioned with Citric Acid-Coated Antioxidant-Functionalized Magnetic Nanoparticles. Med (Mex) 59:587. https:\/\/doi.org\/10.3390\/medicina59030587","journal-title":"Med (Mex)"},{"key":"12534_CR49","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s13287-025-04545-6","volume":"16","author":"B-Y Wang","year":"2025","unstructured":"Wang B-Y, Zhang X, Li T-T et al (2025) Ultrasound assisted homing of human umbilical cord mesenchymal stem cells promotes recovery from acute respiratory distress syndrome. Stem Cell Res Ther 16:407. https:\/\/doi.org\/10.1186\/s13287-025-04545-6","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR50","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13287-019-1532-2","volume":"11","author":"N Sahu","year":"2020","unstructured":"Sahu N, Budhiraja G, Subramanian A (2020) Preconditioning of mesenchymal stromal cells with low-intensity ultrasound: influence on chondrogenesis and directed SOX9 signaling pathways. Stem Cell Res Ther 11:6. https:\/\/doi.org\/10.1186\/s13287-019-1532-2","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR51","doi-asserted-by":"publisher","first-page":"874698","DOI":"10.3389\/fimmu.2022.874698","volume":"13","author":"MA Skibber","year":"2022","unstructured":"Skibber MA, Olson SD, Prabhakara KS et al (2022) Enhancing Mesenchymal Stromal Cell Potency: Inflammatory Licensing via Mechanotransduction. Front Immunol 13:874698. https:\/\/doi.org\/10.3389\/fimmu.2022.874698","journal-title":"Front Immunol"},{"key":"12534_CR52","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.bioactmat.2022.11.007","volume":"23","author":"H Zhou","year":"2023","unstructured":"Zhou H, He Y, Xiong W et al (2023) MSC based gene delivery methods and strategies improve the therapeutic efficacy of neurological diseases. Bioact Mater 23:409\u2013437. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.11.007","journal-title":"Bioact Mater"},{"key":"12534_CR53","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3390\/pharmaceutics13060913","volume":"13","author":"Y Ding","year":"2021","unstructured":"Ding Y, Wang C, Sun Z et al (2021) Mesenchymal Stem Cells Engineered by Nonviral Vectors: A Powerful Tool in Cancer Gene Therapy. Pharmaceutics 13:913. https:\/\/doi.org\/10.3390\/pharmaceutics13060913","journal-title":"Pharmaceutics"},{"key":"12534_CR54","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13287-021-02193-0","volume":"12","author":"R Herv\u00e1s-Salcedo","year":"2021","unstructured":"Herv\u00e1s-Salcedo R, Fern\u00e1ndez-Garc\u00eda M, Hernando-Rodr\u00edguez M et al (2021) Enhanced anti-inflammatory effects of mesenchymal stromal cells mediated by the transient ectopic expression of CXCR4 and IL10. Stem Cell Res Ther 12:124. https:\/\/doi.org\/10.1186\/s13287-021-02193-0","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR55","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1007\/s12015-023-10518-0","volume":"19","author":"F Shu","year":"2023","unstructured":"Shu F, Lu J, Zhang W et al (2023) JAM-A Overexpression in Human Umbilical Cord-Derived Mesenchymal Stem Cells Accelerated the Angiogenesis of Diabetic Wound By Enhancing Both Paracrine Function and Survival of Mesenchymal Stem Cells. Stem Cell Rev Rep 19:1554\u20131575. https:\/\/doi.org\/10.1007\/s12015-023-10518-0","journal-title":"Stem Cell Rev Rep"},{"key":"12534_CR56","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.4103\/1673-5374.358609","volume":"18","author":"C Liu","year":"2023","unstructured":"Liu C, Yang Z-X, Zhou S-Q et al (2023) Overexpression of vascular endothelial growth factor enhances the neuroprotective effects of bone marrow mesenchymal stem cell transplantation in ischemic stroke. Neural Regen Res 18:1286. https:\/\/doi.org\/10.4103\/1673-5374.358609","journal-title":"Neural Regen Res"},{"key":"12534_CR57","doi-asserted-by":"publisher","first-page":"szae094","DOI":"10.1093\/stcltm\/szae094","volume":"14","author":"A Cressman","year":"2025","unstructured":"Cressman A, Le B, Morales D et al (2025) Investigational New Drug-enabling studies to use genetically modified mesenchymal stromal cells in patients with critical limb ischemia. Stem Cells Transl Med 14:szae094. https:\/\/doi.org\/10.1093\/stcltm\/szae094","journal-title":"Stem Cells Transl Med"},{"key":"12534_CR58","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s13346-023-01289-9","volume":"13","author":"L Stahn","year":"2023","unstructured":"Stahn L, Rasi\u0144ska J, Dehne T et al (2023) Sleeping Beauty transposon system for GDNF overexpression of entrapped stem cells in fibrin hydrogel in a rat model of Parkinson\u2019s disease. Drug Deliv Transl Res 13:1745\u20131765. https:\/\/doi.org\/10.1007\/s13346-023-01289-9","journal-title":"Drug Deliv Transl Res"},{"key":"12534_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/8833527","volume":"2021","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, Xing X, Huang S, Tu Y (2021) NAT10 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells by Mediating N4-Acetylcytidine Modification of Gremlin 1. Stem Cells Int 2021:1\u201310. https:\/\/doi.org\/10.1155\/2021\/8833527","journal-title":"Stem Cells Int"},{"key":"12534_CR60","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/ph16030436","volume":"16","author":"BY Choi","year":"2023","unstructured":"Choi BY, Hong DK, Kang BS et al (2023) Engineered Mesenchymal Stem Cells Over-Expressing BDNF Protect the Brain from Traumatic Brain Injury-Induced Neuronal Death, Neurological Deficits, and Cognitive Impairments. Pharmaceuticals 16:436. https:\/\/doi.org\/10.3390\/ph16030436","journal-title":"Pharmaceuticals"},{"key":"12534_CR61","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13287-021-02205-z","volume":"12","author":"B Xue","year":"2021","unstructured":"Xue B, Xiao X, Yu T et al (2021) Mesenchymal stem cells modified by FGF21 and GLP1 ameliorate lipid metabolism while reducing blood glucose in type 2 diabetic mice. Stem Cell Res Ther 12:133. https:\/\/doi.org\/10.1186\/s13287-021-02205-z","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR62","doi-asserted-by":"publisher","first-page":"7086","DOI":"10.3390\/ijms22137086","volume":"22","author":"P Borkowska","year":"2021","unstructured":"Borkowska P, Zielinska A, Paul-Samojedny M et al (2021) Synergistic Effect of the Long-Term Overexpression of Bcl-2 and BDNF Lentiviral in Cell Protecting against Death and Generating TH Positive and CHAT Positive Cells from MSC. Int J Mol Sci 22:7086. https:\/\/doi.org\/10.3390\/ijms22137086","journal-title":"Int J Mol Sci"},{"key":"12534_CR63","doi-asserted-by":"publisher","first-page":"e70621","DOI":"10.1111\/cns.70621","volume":"31","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhang L, Wang J et al (2025) Genetic Modification of Mesenchymal Stem Cell to Overexpress CXCR4 Enhances Treatment Efficacy for Brain Injury After Cardiopulmonary Resuscitation. CNS Neurosci Ther 31:e70621. https:\/\/doi.org\/10.1111\/cns.70621","journal-title":"CNS Neurosci Ther"},{"key":"12534_CR64","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1186\/s13287-025-04762-z","volume":"16","author":"GC Santos","year":"2025","unstructured":"Santos GC, Azevedo CM, Ribeiro TO et al (2025) Mesenchymal stem\/stromal cells overexpressing leukemia inhibitory factor (LIF) promote arteriogenesis and functional recovery in a mouse model of critical hindlimb ischemia. Stem Cell Res Ther 16:660. https:\/\/doi.org\/10.1186\/s13287-025-04762-z","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13287-022-02729-y","volume":"13","author":"R Xu","year":"2022","unstructured":"Xu R, Ni B, Wang L et al (2022) CCR2-overexpressing mesenchymal stem cells targeting damaged liver enhance recovery of acute liver failure. Stem Cell Res Ther 13:55. https:\/\/doi.org\/10.1186\/s13287-022-02729-y","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR66","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13287-023-03501-6","volume":"14","author":"A Selich","year":"2023","unstructured":"Selich A, Fleischauer J, Roepke T et al (2023) Inflammation-inducible promoters to overexpress immune inhibitory factors by MSCs. Stem Cell Res Ther 14:270. https:\/\/doi.org\/10.1186\/s13287-023-03501-6","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR67","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3390\/cells9040873","volume":"9","author":"AA Hombach","year":"2020","unstructured":"Hombach AA, Geumann U, G\u00fcnther C et al (2020) IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells. Cells 9:873. https:\/\/doi.org\/10.3390\/cells9040873","journal-title":"Cells"},{"key":"12534_CR68","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3390\/cells13100859","volume":"13","author":"AI Nyk\u00e4nen","year":"2024","unstructured":"Nyk\u00e4nen AI, Mariscal A, Duong A et al (2024) Lung Transplant Immunomodulation with Genetically Engineered Mesenchymal Stromal Cells\u2014Therapeutic Window for Interleukin-10. Cells 13:859. https:\/\/doi.org\/10.3390\/cells13100859","journal-title":"Cells"},{"key":"12534_CR69","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4103\/1673-5374.375328","volume":"19","author":"AA Shaimardanova","year":"2024","unstructured":"Shaimardanova AA, Chulpanova DS, Solovyeva VV et al (2024) Increasing \u03b2-hexosaminidase A activity using genetically modified mesenchymal stem cells. Neural Regen Res 19:212\u2013219. https:\/\/doi.org\/10.4103\/1673-5374.375328","journal-title":"Neural Regen Res"},{"key":"12534_CR70","doi-asserted-by":"publisher","unstructured":"State Key Laboratory of Ophthalmology, Center ZO, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, Guangdong Province, China, Wang T, Ma J et al (2024) Effect of Sonic hedgehog gene-modified bone marrow mesenchymal stem cells on graft-induced retinal gliosis and retinal ganglion cells survival in diabetic mice. Int J Ophthalmol 17:34\u201341. https:\/\/doi.org\/10.18240\/ijo.2024.01.05","DOI":"10.18240\/ijo.2024.01.05"},{"key":"12534_CR71","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3390\/biomedicines10030555","volume":"10","author":"L-Y Chan","year":"2022","unstructured":"Chan L-Y, Chang C-C, Lai P-L et al (2022) Cre\/LoxP Genetic Recombination Sustains Cartilage Anabolic Factor Expression in Hyaluronan Encapsulated MSCs Alleviates Intervertebral Disc Degeneration. Biomedicines 10:555. https:\/\/doi.org\/10.3390\/biomedicines10030555","journal-title":"Biomedicines"},{"key":"12534_CR72","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13287-025-04423-1","volume":"16","author":"H Kang","year":"2025","unstructured":"Kang H, Kim O-H, Chang ES et al (2025) Enhanced engraftment and immunomodulatory effects of integrin alpha-2-overexpressing mesenchymal stromal cells in lipopolysaccharide-induced acute lung injury. Stem Cell Res Ther 16:286. https:\/\/doi.org\/10.1186\/s13287-025-04423-1","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR73","doi-asserted-by":"publisher","first-page":"14257","DOI":"10.1038\/s41598-020-71224-2","volume":"10","author":"YK Ho","year":"2020","unstructured":"Ho YK, Woo JY, Tu GXE et al (2020) A highly efficient non-viral process for programming mesenchymal stem cells for gene directed enzyme prodrug cancer therapy. Sci Rep 10:14257. https:\/\/doi.org\/10.1038\/s41598-020-71224-2","journal-title":"Sci Rep"},{"key":"12534_CR74","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s13287-020-01899-x","volume":"11","author":"GXE Tu","year":"2020","unstructured":"Tu GXE, Ho YK, Ng ZX et al (2020) A facile and scalable in production non-viral gene engineered mesenchymal stem cells for effective suppression of temozolomide-resistant (TMZR) glioblastoma growth. Stem Cell Res Ther 11:391. https:\/\/doi.org\/10.1186\/s13287-020-01899-x","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR75","doi-asserted-by":"publisher","first-page":"117676","DOI":"10.1016\/j.biopha.2024.117676","volume":"181","author":"XN Ma","year":"2024","unstructured":"Ma XN, Ho YK, Goie JYG et al (2024) Evaluating the potential of off-the-shelf engineered mesenchymal stem cells for targeted Hepatocellular Carcinoma treatment: A multisite proof-of-concept study. Biomed Pharmacother 181:117676. https:\/\/doi.org\/10.1016\/j.biopha.2024.117676","journal-title":"Biomed Pharmacother"},{"key":"12534_CR76","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13287-024-03806-0","volume":"15","author":"MJ Cantero","year":"2024","unstructured":"Cantero MJ, Bueloni B, Gonzalez Llamazares L et al (2024) Modified mesenchymal stromal cells by in vitro transcribed mRNA: a therapeutic strategy for hepatocellular carcinoma. Stem Cell Res Ther 15:208. https:\/\/doi.org\/10.1186\/s13287-024-03806-0","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR77","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1158\/2767-9764.CRC-25-0209","volume":"5","author":"DO Kim","year":"2025","unstructured":"Kim DO, Jang EH, Kwon YD et al (2025) Mesenchymal Stem Cells Expressing CES1 and Soluble TRAIL Activate CPT-11 and Induce Apoptosis in Lung Cancer Brain Metastatic Lesions. Cancer Res Commun 5:1552\u20131565. https:\/\/doi.org\/10.1158\/2767-9764.CRC-25-0209","journal-title":"Cancer Res Commun"},{"key":"12534_CR78","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s11658-022-00325-9","volume":"27","author":"T Gao","year":"2022","unstructured":"Gao T, Huang F, Wang W et al (2022) Interleukin-10 genetically modified clinical-grade mesenchymal stromal cells markedly reinforced functional recovery after spinal cord injury via directing alternative activation of macrophages. Cell Mol Biol Lett 27:27. https:\/\/doi.org\/10.1186\/s11658-022-00325-9","journal-title":"Cell Mol Biol Lett"},{"key":"12534_CR79","doi-asserted-by":"publisher","first-page":"112","DOI":"10.15283\/ijsc20117","volume":"14","author":"JY Kim","year":"2021","unstructured":"Kim JY, Choi JH, Kim SH et al (2021) Efficacy of Gene Modification in Placenta-Derived Mesenchymal Stem Cells Based on Nonviral Electroporation. Int J Stem Cells 14:112\u2013118. https:\/\/doi.org\/10.15283\/ijsc20117","journal-title":"Int J Stem Cells"},{"key":"12534_CR80","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s13287-020-01982-3","volume":"11","author":"JY Kim","year":"2020","unstructured":"Kim JY, Park S, Lee H-J et al (2020) Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves\u2019 ophthalmopathy. Stem Cell Res Ther 11:469. https:\/\/doi.org\/10.1186\/s13287-020-01982-3","journal-title":"Stem Cell Res Ther"},{"key":"12534_CR81","doi-asserted-by":"crossref","unstructured":"O\u2019Dea S (2025) Engineering Mesenchymal Stem Cells Using Electroporation. In: Mesenchymal Stem Cells - Biology, Therapeutics, and Beyond. IntechOpen","DOI":"10.5772\/intechopen.1012365"},{"key":"12534_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15283\/ijsc23030","volume":"17","author":"DE Yoon","year":"2023","unstructured":"Yoon DE, Lee H, Kim K (2023) Recent Research Trends in Stem Cells Using CRISPR\/Cas-Based Genome Editing Methods. Int J Stem Cells 17:1\u201314. https:\/\/doi.org\/10.15283\/ijsc23030","journal-title":"Int J Stem Cells"},{"key":"12534_CR83","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-0716-2301-5_2","volume-title":"Applications of Genome Modulation and Editing","author":"Y Shamshirgaran","year":"2022","unstructured":"Shamshirgaran Y, Liu J, Sumer H et al (2022) Tools for Efficient Genome Editing; ZFN, TALEN, and CRISPR. In: Verma PJ, Sumer H, Liu J (eds) Applications of Genome Modulation and Editing. Springer US, New York, NY, pp 29\u201346"},{"key":"12534_CR84","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.3390\/life14121640","volume":"14","author":"IJ Lara-Navarro","year":"2024","unstructured":"Lara-Navarro IJ, Jave-Su\u00e1rez LF, Marchal JA, Jaloma-Cruz AR (2024) CRISPR\/Cas9 Edition of the F9 Gene in Human Mesenchymal Stem Cells for Hemophilia B Therapy. Life 14:1640. https:\/\/doi.org\/10.3390\/life14121640","journal-title":"Life"},{"key":"12534_CR85","doi-asserted-by":"publisher","first-page":"60","DOI":"10.5483\/BMBRep.2023-0113","volume":"57","author":"AR Han","year":"2024","unstructured":"Han AR, Shin HR, Kweon J et al (2024) Highly efficient genome editing via CRISPR-Cas9 ribonucleoprotein (RNP) delivery in mesenchymal stem cells. BMB Rep 57:60\u201365. https:\/\/doi.org\/10.5483\/BMBRep.2023-0113","journal-title":"BMB Rep"},{"key":"12534_CR86","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.1038\/s41598-023-31286-4","volume":"13","author":"Y Schary","year":"2023","unstructured":"Schary Y, Rotem I, Caller T et al (2023) CRISPR-Cas9 editing of TLR4 to improve the outcome of cardiac cell therapy. Sci Rep 13:4481. https:\/\/doi.org\/10.1038\/s41598-023-31286-4","journal-title":"Sci Rep"},{"key":"12534_CR87","unstructured":"Research C for, BE (2020) and Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/regulatory-considerations-human-cells-tissues-and-cellular-and-tissue-based-products-minimal. Accessed 13 Oct 2024"},{"key":"12534_CR88","unstructured":"Research C for, BE (2024) and Human Gene Therapy Products Incorporating Human Genome Editing. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/human-gene-therapy-products-incorporating-human-genome-editing. Accessed 13 Oct 2024"},{"key":"12534_CR89","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-031-34567-8_6","volume-title":"Regulatory Aspects of Gene Therapy and Cell Therapy Products","author":"J Wang","year":"2023","unstructured":"Wang J, Griffiths E, Tounekti O et al (2023) Canadian Regulatory Framework and Regulatory Requirements for Cell and Gene Therapy Products. In: Galli MC (ed) Regulatory Aspects of Gene Therapy and Cell Therapy Products. Springer International Publishing, Cham, pp 91\u2013116"},{"key":"12534_CR90","doi-asserted-by":"publisher","first-page":"104453","DOI":"10.1016\/j.drudis.2025.104453","volume":"30","author":"LS Germain","year":"2025","unstructured":"Germain LS, Winn LM (2025) Commercialization of cell and gene therapy in Canada: Current landscape, challenges and opportunities. Drug Discov Today 30:104453. https:\/\/doi.org\/10.1016\/j.drudis.2025.104453","journal-title":"Drug Discov Today"},{"key":"12534_CR91","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/med.21659","volume":"40","author":"J L\u00f3pez-Beas","year":"2020","unstructured":"L\u00f3pez-Beas J, Guadix JA, Clares B et al (2020) An overview of international regulatory frameworks for mesenchymal stromal cell\u2010based medicinal products: From laboratory to patient. Med Res Rev 40:1315\u20131334. https:\/\/doi.org\/10.1002\/med.21659","journal-title":"Med Res Rev"},{"key":"12534_CR92","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1016\/j.clinthera.2021.02.006","volume":"43","author":"C Pimenta","year":"2021","unstructured":"Pimenta C, Bettiol V, Alencar-Silva T et al (2021) Advanced Therapies and Regulatory Framework in Different Areas of the Globe: Past, Present, and Future. Clin Ther 43:e103\u2013e138. https:\/\/doi.org\/10.1016\/j.clinthera.2021.02.006","journal-title":"Clin Ther"},{"key":"12534_CR93","unstructured":"Administration (TGA) TG (2024) Understanding the minimal manipulation method of preparation for biologicals | Therapeutic Goods Administration (TGA). https:\/\/www.tga.gov.au\/resources\/guidance\/understanding-minimal-manipulation-method-preparation-biologicals. Accessed 2 Feb 2026"},{"key":"12534_CR94","unstructured":"Administration (TGA) TG (2024) Classifying biologicals | Therapeutic Goods Administration (TGA). https:\/\/www.tga.gov.au\/resources\/guidance\/classifying-biologicals. Accessed 2 Feb 2026"},{"key":"12534_CR95","doi-asserted-by":"publisher","first-page":"e13217","DOI":"10.1111\/cpr.13217","volume":"55","author":"J Gao","year":"2022","unstructured":"Gao J, Gao C (2022) Development and regulation of stem cell-based therapies in China. Cell Prolif 55:e13217. https:\/\/doi.org\/10.1111\/cpr.13217","journal-title":"Cell Prolif"},{"key":"12534_CR96","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s44178-024-00123-7","volume":"3","author":"M Hong","year":"2024","unstructured":"Hong M, Yan Z (2024) The development and challenges of Investigator-Initiated Trials (IITs) in China. Holist Integr Oncol 3:57. https:\/\/doi.org\/10.1007\/s44178-024-00123-7","journal-title":"Holist Integr Oncol"},{"key":"12534_CR97","doi-asserted-by":"publisher","first-page":"1486812","DOI":"10.3389\/fphar.2024.1486812","volume":"15","author":"J Yoon","year":"2025","unstructured":"Yoon J, Lee S, Kim MJ, Kim J-H (2025) Brief summary of the regulatory frameworks of regenerative medicine therapies. Front Pharmacol 15:1486812. https:\/\/doi.org\/10.3389\/fphar.2024.1486812","journal-title":"Front Pharmacol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12534-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12534-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12534-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:08:17Z","timestamp":1785841697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12534-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12534"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12534-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1341"}}